Ardelyx Insider Trades
NASDAQ: ARDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 1 · $1.95M
- Sales
- 71 · $3.50M
- Shares bought / sold
- 333.33K / 631.20K
- Net activity
- Net selling $1.6 million
Ardelyx insider activity
Over the last 12 months, Ardelyx insiders reported 89 transactions on SEC Form 4: 1 open-market purchase and 71 sales. Insiders bought $1.9 million and sold $3.5 million worth of stock, for net insider selling of $1.6 million. The largest seller was RAAB MICHAEL, with $2.3 million in reported sales.
The most recent filing shows Reilly Joseph James (See Remarks) selling 2,872 shares at $3.86 on Aug 21, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ARDX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ARDX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 19,178 | $73.97K | Form 4 |
| Aug 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 8,411 | $32.44K | Form 4 |
| Aug 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 15,976 | $61.62K | Form 4 |
| Aug 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 15,009 | $57.89K | Form 4 |
| Aug 21, 2026 | Williams Laura AChief Patient Officer | Sale | 1,734 | $6.69K | Form 4 |
| Aug 21, 2026 | Williams Laura AChief Patient Officer | Sale | 2,430 | $9.37K | Form 4 |
| Aug 21, 2026 | Williams Laura AChief Patient Officer | Sale | 3,089 | $11.91K | Form 4 |
| Aug 21, 2026 | Williams Laura AChief Patient Officer | Sale | 3,486 | $13.45K | Form 4 |
| Aug 21, 2026 | Kelliher MikeChief Business Officer | Sale | 2,002 | $7.72K | Form 4 |
| Aug 21, 2026 | Kelliher MikeChief Business Officer | Sale | 2,652 | $10.23K | Form 4 |
| Aug 21, 2026 | Kelliher MikeChief Business Officer | Sale | 3,104 | $11.97K | Form 4 |
| Aug 21, 2026 | Brady James ParkerChief Human Resources Officer | Sale | 13,160 | $50.76K | Form 4 |
| Aug 21, 2026 | Brady James ParkerChief Human Resources Officer | Sale | 1,976 | $7.62K | Form 4 |
| Aug 21, 2026 | Bishop John ESee Remarks | Sale | 2,469 | $9.52K | Form 4 |
| Aug 21, 2026 | Bishop John ESee Remarks | Sale | 17,281 | $66.65K | Form 4 |
| Aug 21, 2026 | Hohenleitner SusanChief Financial Officer | Sale | 1,558 | $6.01K | Form 4 |
| Aug 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 2,575 | $9.93K | Form 4 |
| Aug 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 3,389 | $13.07K | Form 4 |
| Aug 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 2,598 | $10.02K | Form 4 |
| Aug 21, 2026 | Reilly Joseph JamesSee Remarks | Sale | 1,110 | $4.28K | Form 4 |
| Aug 21, 2026 | Reilly Joseph JamesSee Remarks | Sale | 2,872 | $11.08K | Form 4 |
| Jul 15, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,668 | $210.92K | Form 4 |
| Jul 15, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,834 | $20.63K | Form 4 |
| Jun 18, 2026 | Williams Laura AChief Patient Officer | Sale | 81,898 | $490.49K | Form 4 |
| Jun 18, 2026 | Williams Laura AChief Patient Officer | Option exercise | 31,000 | $30.69K | Form 4 |
| Jun 16, 2026 | Bazemore Robert BDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | Bertrand William C JRDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | Bertrand William C JRDirector | Award | 12,345 | — | Form 4 |
| Jun 16, 2026 | Bhanji MunaDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | Rodgers Richard JDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | Cadoret-Manier OnaizaDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | MOTT DAVID MDirector | Award | 26,455 | — | Form 4 |
| Jun 16, 2026 | MOTT DAVID MDirector | Award | 20,282 | — | Form 4 |
| Jun 16, 2026 | Parsey MerdadDirector | Award | 26,455 | — | Form 4 |
| Jun 15, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,666 | $236.35K | Form 4 |
| Jun 15, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,833 | $20.62K | Form 4 |
| May 21, 2026 | Williams Laura AChief Patient Officer | Sale | 1,418 | $8.89K | Form 4 |
| May 21, 2026 | Williams Laura AChief Patient Officer | Sale | 1,911 | $11.98K | Form 4 |
| May 21, 2026 | Williams Laura AChief Patient Officer | Sale | 2,157 | $13.52K | Form 4 |
| May 21, 2026 | Williams Laura AChief Patient Officer | Sale | 1,503 | $9.42K | Form 4 |
| May 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 2,405 | $15.07K | Form 4 |
| May 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 2,427 | $15.21K | Form 4 |
| May 21, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 3,166 | $19.84K | Form 4 |
| May 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 14,028 | $87.92K | Form 4 |
| May 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 17,926 | $112.35K | Form 4 |
| May 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 7,861 | $49.27K | Form 4 |
| May 21, 2026 | RAAB MICHAELPresident & CEO | Sale | 14,933 | $93.59K | Form 4 |
| May 21, 2026 | Kelliher MikeChief Business Officer | Sale | 2,478 | $15.53K | Form 4 |
| May 21, 2026 | Kelliher MikeChief Business Officer | Sale | 1,870 | $11.72K | Form 4 |
| May 21, 2026 | Kelliher MikeChief Business Officer | Sale | 2,900 | $18.18K | Form 4 |
| May 21, 2026 | Brady James ParkerChief Human Resources Officer | Sale | 1,846 | $11.57K | Form 4 |
| May 21, 2026 | Bishop John ESee Remarks | Sale | 2,306 | $14.45K | Form 4 |
| May 21, 2026 | Hohenleitner SusanChief Financial Officer | Sale | 1,455 | $9.12K | Form 4 |
| May 21, 2026 | Reilly Joseph JamesSee Remarks | Sale | 1,036 | $6.49K | Form 4 |
| May 21, 2026 | Reilly Joseph JamesSee Remarks | Sale | 2,683 | $16.82K | Form 4 |
| May 15, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,666 | $261.61K | Form 4 |
| May 15, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,833 | $20.62K | Form 4 |
| Apr 15, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,668 | $261.95K | Form 4 |
| Apr 15, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,834 | $20.63K | Form 4 |
| Mar 16, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,666 | $243.33K | Form 4 |
| Mar 16, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,833 | $20.62K | Form 4 |
| Feb 24, 2026 | RAAB MICHAELPresident & CEO | Sale | 41,666 | $260.62K | Form 4 |
| Feb 24, 2026 | RAAB MICHAELPresident & CEO | Option exercise | 20,833 | $20.62K | Form 4 |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO | Sale | 2 | $11.40 | Form 4 |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO | Sale | 1 | $5.70 | Form 4 |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO | Sale | 2 | $11.40 | Form 4 |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO | Sale | 5,576 | $31.86K | Form 4 |
| Feb 20, 2026 | RAAB MICHAELPresident & CEO | Sale | 40,401 | $236.95K | Form 4 |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sale | 2 | $11.41 | Form 4 |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sale | 1,159 | $6.62K | Form 4 |
| Feb 20, 2026 | Kelliher MikeSee Remarks | Sale | 8,434 | $49.47K | Form 4 |
| Feb 20, 2026 | Brady James ParkerChief Human Resources Officer | Sale | 309 | $1.77K | Form 4 |
| Feb 20, 2026 | Brady James ParkerChief Human Resources Officer | Sale | 2,234 | $13.10K | Form 4 |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 1 | $5.70 | Form 4 |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 1 | $5.71 | Form 4 |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 1,261 | $7.21K | Form 4 |
| Feb 20, 2026 | Foster Eric DuaneChief Commercial Officer | Sale | 9,176 | $53.82K | Form 4 |
| Feb 20, 2026 | Hohenleitner SusanChief Financial Officer | Sale | 247 | $1.41K | Form 4 |
| Feb 20, 2026 | Hohenleitner SusanChief Financial Officer | Sale | 1,786 | $10.47K | Form 4 |
| Feb 20, 2026 | Williams Laura ASee Remarks | Sale | 984 | $5.62K | Form 4 |
| Feb 20, 2026 | Williams Laura ASee Remarks | Sale | 7,192 | $42.18K | Form 4 |
| Feb 20, 2026 | Bishop John ESee Remarks | Sale | 1 | $5.70 | Form 4 |
| Feb 20, 2026 | Bishop John ESee Remarks | Sale | 386 | $2.21K | Form 4 |
| Feb 20, 2026 | Bishop John ESee Remarks | Sale | 2,792 | $16.38K | Form 4 |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks | Sale | 2 | $11.40 | Form 4 |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks | Sale | 602 | $3.44K | Form 4 |
| Feb 20, 2026 | Reilly Joseph JamesSee Remarks | Sale | 4,387 | $25.73K | Form 4 |
| Feb 20, 2026 | MOTT DAVID MDirector | Buy | 333,333 | $1.95M | Form 4 |
| Jan 23, 2026 | Reilly Joseph JamesSee Remarks | Award | 46,200 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4